| 查看: 2197 | 回复: 6 | |||
[交流]
《Canadian Journal of Gastroenterology and Hepatology》(影响因子2.307)征稿启示 已有3人参与
|
|
《Canadian Journal of Gastroenterology and Hepatology》征稿启事 此期刊现有专栏征稿，“Immunometabolic Disorders and Liver Diseases”，欢迎各位感兴趣的老师，同学投稿。链接：https://www.hindawi.com/journals/cjgh/si/518262/cfp/ Immunometabolic Disorders and Liver Diseases Call for Papers The prevalence of metabolic liver diseases (MLD) is increasing dramatically in both developing and industrialized countries, causing a big burden to society. MLD is largely attributed to unhealthy lifestyle choices, including caloric-over-consumption, lack of exercise, and circadian rhythm disruption. Notably, unresolved metabolic disorders, accompanied by chronic inflammation, will cause liver damage and fibrosis and eventually promote hepatocellular carcinoma. Therefore, elucidation of mechanisms underlying MLD progression together with development of efficient therapeutic strategies against it is essential and urgent. In recent years, a noticeable number of findings have unveiled the modulation of metabolic homeostasis by the immune system. In the setting of MLD, metabolic stress (e.g., liver steatosis, hypoxia) predisposes liver cells to injury caused by dysregulated inflammatory responses and aberrant cytokine production, which in turn exacerbates metabolic comorbidities. Accordingly, intrahepatic immune cells as well as hepatic inflammatory pathways are promising targets for strategies against MLD. This special issue is to promote the researches that investigate the interplay between inflammatory/immune pathways and metabolic liver diseases, which will provide novel insights into this emerging field. Research articles and reviews relating to liver metabolism, inflammation, and immunity are especially encouraged to be submitted to this special issue. Potential topics include but are not limited to the following: Hepatic glucose/lipid disorders and immune response Alcoholic liver disease and immune responses Nonalcoholic fatty liver disease (NAFLD) and immune responses MLD and liver inflammation MLD and liver injury/fibrosis Epidemiological studies of MLD and immune system Clinical studies involved in MLD and immune responses Pharmaceutical investigation of MLD treatment Authors can submit their manuscripts through the Manuscript Tracking System at https://mts.hindawi.com/submit/journals/cjgh/hepatology/mld/. Submission Deadline Friday, 27 October 2017 Publication Date March 2018 Papers are published upon acceptance, regardless of the Special Issue publication date. Lead Guest Editor Hong Shen, University of Michigan, Ann Arbor, USA Guest Editors Mark J. Canet, University of Michigan, Ann Arbor, USA Liang Sheng, Nanjing Medical University, Nanjing, China Feihua Wu, China Pharmaceutical University, Nanjing, China Kae W. Cho, Soonchunhyang University, Asan, Republic of Korea Qilin Gu, Houston Methodist Research Institute, Houston, USA |
回复此楼» 猜你喜欢
售SCI一区T0P文章，我:8.O.55.1.O.5.4,科目全,可+急
已经有6人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有6人回复
-
【长期招聘】复旦大学 AI 制药实验室 博士后招聘
已经有11人回复
-
售SCI一区T0P文章，我:8.O.55.1.O.5.4,科目全,可+急
已经有7人回复
-
2027博士申请-临床检验诊断学、病原生物学、微生物方向
已经有5人回复
-
各位基础老师们，看完中央《从严治党》的决定后，对学术界更加有信心了吧
已经有4人回复
-
申博自荐 2篇一区TOP+1篇EI+2公开发明专利 2027博士申请
已经有3人回复
 |
2楼2017-08-19 09:06:13
 |
3楼2017-08-19 10:39:00
|
|
4楼2017-08-19 18:15:32
|
|
5楼2017-08-21 07:33:16
|
|
6楼2017-08-21 09:15:28
|
|
7楼2017-08-22 11:19:24